MACROPHAGE HETEROGENEITY AFTER SPINAL CORD INJURY

脊髓损伤后的巨噬细胞异质性

基本信息

  • 批准号:
    6540008
  • 负责人:
  • 金额:
    $ 23.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-04-05 至 2004-03-31
  • 项目状态:
    已结题

项目摘要

This research will investigate to what extent the reparative potential of macrophages exists within the traumatically injured spinal cord. Historically, macrophages have been considered inflammatory scavenger cells in the CNS, capable only of removing cellular debris at sites of injury or infection. Now, many functions have been attributed to these cells including the ability to promote blood vessel growth, myelination, and neurite sprouting/regeneration. Unfortunately, these same cells can promote demyelination and cell injury. How and under what conditions macrophages effect such a broad range of biological functions is not clear, but may result from changes in the lesion microenvironment. It is the major hypothesis of this proposal that the inherent ability of macrophages to promote tissue repair and functional recovery changes as a function of time after spinal cord injury (SCI) and is negatively influenced by the accumulation of blood-borne elements (cells and proteins) at the injury site. Using radiation bone marrow chimeric rats in combination with macrophage and complement-depletion protocols, we will examine how these vascular constituents influence resident (microglia) and recruited (blood-derived) macrophage activation and function. Specifically, the neurotrophic and oxidative capacity of each macrophage subpopulation will be evaluated in vivo using immunohistochemistry and in vitro using cytokines and other factors present in the injury site to trigger macrophage effector functions. Cells exhibiting neurotrophic secretory profiles will be transplanted into injured rat spinal cords to test their ability to promote regeneration and functional recovery. By learning more about the factors that influence macrophage function in the injured CNS, we may be able to harness the innate reparative potential of the inflammatory response (specifically macrophages) to promote functional regeneration. Moreover, we will be determining the feasibility of manipulating an intrinsic component of the injury site to promote tissue repair. Such an approach may be biologically and clinically advantageous and could eliminate the need for chronic drug therapy.
这项研究将调查巨噬细胞在多大程度上存在于创伤损伤的脊髓内。在历史上,巨噬细胞一直被认为是中枢神经系统中的炎性清道夫细胞,只能在损伤或感染部位清除细胞碎片。现在,许多功能都归因于这些细胞,包括促进血管生长、髓鞘形成和轴突萌发/再生的能力。不幸的是,这些细胞可以促进脱髓鞘和细胞损伤。巨噬细胞如何以及在什么条件下影响如此广泛的生物学功能尚不清楚,但可能是病变微环境变化的结果。这一假设的主要假设是,脊髓损伤后巨噬细胞促进组织修复和功能恢复的固有能力随时间变化,并受到损伤部位血源性成分(细胞和蛋白质)积累的负面影响。使用放射骨髓嵌合大鼠,结合巨噬细胞和补体耗竭方案,我们将检查这些血管成分如何影响驻留(小胶质细胞)和招募(血液来源)巨噬细胞的激活和功能。具体地说,每个巨噬细胞亚群的神经营养和氧化能力将在体内使用免疫组织化学进行评估,并在体外使用损伤部位存在的细胞因子和其他因素来触发巨噬细胞效应功能。表现出神经营养分泌特征的细胞将被移植到受损的大鼠脊髓中,以测试它们促进再生和功能恢复的能力。通过更多地了解影响受损中枢神经系统巨噬细胞功能的因素,我们可能能够利用炎症反应(特别是巨噬细胞)的固有修复潜力来促进功能再生。此外,我们将确定操纵损伤部位的固有成分以促进组织修复的可行性。这种方法可能在生物学和临床上都是有利的,并可能消除对慢性药物治疗的需要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILLIP G POPOVICH其他文献

PHILLIP G POPOVICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILLIP G POPOVICH', 18)}}的其他基金

Overcoming Neurogenic “Meta-Inflammation” to Promote Recovery After Spinal Cord Injury
克服神经源性“元炎症”以促进脊髓损伤后的恢复
  • 批准号:
    10634510
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
Eighteenth International Symposium on Neural Regeneration (ISNR)
第十八届国际神经再生研讨会(ISNR)
  • 批准号:
    9913669
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
Overcoming Neurogenic “Meta-Inflammation” to Promote Recovery After Spinal Cord Injury
克服神经源性“元炎症”以促进脊髓损伤后的恢复
  • 批准号:
    10400875
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
Overcoming Neurogenic “Meta-Inflammation” to Promote Recovery After Spinal Cord Injury
克服神经源性“元炎症”以促进脊髓损伤后的恢复
  • 批准号:
    10160976
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
Overcoming neurogenic “meta-inflammation” to promote recovery after spinal cord injury
克服神经源性“元炎症”以促进脊髓损伤后的恢复
  • 批准号:
    9924658
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
Role of the spinal cord - gut - immune axis after spinal cord injury
脊髓损伤后脊髓-肠道-免疫轴的作用
  • 批准号:
    9380128
  • 财政年份:
    2017
  • 资助金额:
    $ 23.08万
  • 项目类别:
Glucocorticoids and sensory neuron plasticity
糖皮质激素和感觉神经元可塑性
  • 批准号:
    9381698
  • 财政年份:
    2017
  • 资助金额:
    $ 23.08万
  • 项目类别:
International Symposium on Neural Regeneration
国际神经再生研讨会
  • 批准号:
    8985740
  • 财政年份:
    2015
  • 资助金额:
    $ 23.08万
  • 项目类别:
Preventing autonomic dysreflexia to restore immune function after SCI
预防 SCI 后自主神经反射异常以恢复免疫功能
  • 批准号:
    8812278
  • 财政年份:
    2014
  • 资助金额:
    $ 23.08万
  • 项目类别:
TREM2 regulation of macrophages in spinal cord injury and CNS endogenous repair
TREM2对脊髓损伤和中枢神经系统内源性修复中巨噬细胞的调节
  • 批准号:
    8024876
  • 财政年份:
    2011
  • 资助金额:
    $ 23.08万
  • 项目类别:

相似海外基金

Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
  • 批准号:
    23K08999
  • 财政年份:
    2023
  • 资助金额:
    $ 23.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
  • 批准号:
    2889841
  • 财政年份:
    2023
  • 资助金额:
    $ 23.08万
  • 项目类别:
    Studentship
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
  • 批准号:
    10737358
  • 财政年份:
    2023
  • 资助金额:
    $ 23.08万
  • 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10722602
  • 财政年份:
    2022
  • 资助金额:
    $ 23.08万
  • 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10368246
  • 财政年份:
    2022
  • 资助金额:
    $ 23.08万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10600143
  • 财政年份:
    2022
  • 资助金额:
    $ 23.08万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10370775
  • 财政年份:
    2022
  • 资助金额:
    $ 23.08万
  • 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
  • 批准号:
    10303678
  • 财政年份:
    2021
  • 资助金额:
    $ 23.08万
  • 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
  • 批准号:
    10415200
  • 财政年份:
    2021
  • 资助金额:
    $ 23.08万
  • 项目类别:
Bone Marrow Transplantation in Human Disease
骨髓移植治疗人类疾病
  • 批准号:
    10196999
  • 财政年份:
    2019
  • 资助金额:
    $ 23.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了